OPINION 15:00 GMT 27.08.2021 by Ekaterina Blinova
A new US intelligence report on the origins of COVID-19 does not provide a definitive answer as to how the pandemic started. Retired UN Independent Expert on the Promotion of a Democratic and Equitable International Order Alfred-Maurice de Zayas has sat down with Sputnik to discuss new US attempts to exert pressure on China.Sputnik News: Ex-UN Expert: If US Wants to Conduct COVID Probe In China, It Should Open Its Biolabs to Inspectors
“Safety in a world of user fees” is of paramount concern, concluded Lexchin. That was was back in 2017. Four years on, we are in the biggest health crisis of our lifetimes and the tasks performed by medicines regulators are more important than ever. New experimental vaccines and therapeutic treatments are rolling off the line in record time. But they’re also being authorised in record time — in some cases despite scant evidence of benefits (e.g., Remdesivir). And they’re earning record profits for their manufacturers. At the same time, promising repurposed off-patent medicines that do not offer lucrative financial returns are largely being ignored or are even being demonised by our medicines regulators.